Fennel Extract Composition for Decomposing Maillard Reaction Products
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing therapeutic agents for decomposing advanced glycation end products (AGEs) associated with the Maillard reaction suffer from stability and side effects, and there is a need for a safer and more effective non-therapeutic alternative.
Innovation Solution
A Maillard reaction product-decomposing agent is developed using extracts of fennel, lemon balm, and rosemary, which exhibit higher efficacy in breaking cross-linked structures and collagen cross-links compared to known compounds like N-phenacylthiazolium bromide, with optional inclusion of fenugreek and hibiscus for enhanced performance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If known drugs like PTB and ALT-711 are used to decompose AGEs, then decomposition efficacy is achieved, but stability and side effects worsen
Solution Approach 1:
The patent replaces expensive, unstable synthetic drugs (PTB, ALT-711) with inexpensive, stable plant extracts that can be used safely without causing side effects. The plant extracts serve as disposable, natural alternatives that maintain efficacy while eliminating harmful effects.
Solution Approach 2:
The patent introduces plant extracts as intermediary substances that mediate between the need for AGEs decomposition and the avoidance of synthetic drug side effects. These natural extracts act as safe intermediaries that achieve the desired decomposition without the harmful properties of conventional drugs.
2Productivity
If synthetic Maillard reaction decomposers are used, then decomposition ability is improved, but safety deteriorates
Solution Approach 1:
The patent changes the fundamental parameter of the decomposing agent from synthetic chemical compounds to natural plant extracts. This parameter change transforms the agent's properties to achieve both high decomposition ability and improved safety through natural origin.
Solution Approach 2:
The patent employs plant extracts as safe, natural alternatives to synthetic drugs, using disposable natural materials that maintain decomposition efficacy while eliminating safety concerns associated with synthetic compounds.
3Reliability
If plant extracts are used as Maillard reaction decomposers, then safety and stability are improved, but decomposition efficacy may be reduced
Solution Approach 1:
The patent uses composite plant extracts containing multiple active compounds (flavonoids, phenolic acids, terpenes) that work synergistically to achieve decomposition efficacy comparable to or exceeding synthetic drugs, while maintaining the safety advantages of natural materials.
Solution Approach 2:
The plant extracts serve multiple functions: they decompose AGEs and cross-linked structures, provide antioxidant protection, and enhance stability. This multi-functionality allows plant extracts to match or exceed synthetic drug efficacy while maintaining safety.
Data Source
AI summary
There are provided a new Maillard reaction product-decomposing agent as well as a beverage composition, a food composition, a functional food, a cosmetic, a supplement, a quasi drug, or a pharmaceutical product that contains the agent as an active ingredient. A Maillard reaction product-decomposing agent containing an extract of fennel as an active ingredient. A beverage composition, a food composition, a functional food, a cosmetic, a supplement, a quasi drug, or a pharmaceutical product that contains, as an active ingredient, a Maillard reaction product-decomposing agent containing an extract of fennel as an active ingredient.